WallStreetZenWallStreetZen

NYSE: GRDN
Guardian Pharmacy Services Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GRDN

Based on 4 analysts offering 12 month price targets for Guardian Pharmacy Services Inc

Min Forecast
$44.00-5.36%
Avg Forecast
$46.75+0.56%
Max Forecast
$49.00+5.4%

Should I buy or sell GRDN stock?

Based on 4 analysts offering ratings for Guardian Pharmacy Services Inc.

Strong Buy
Strong Buy
3 analysts 75%
Buy
1 analysts 25%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GRDN's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates GRDN as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +5.11% per year. Learn More

Be the first to know when Wall Street analysts revise their GRDN stock forecasts and price targets.

GRDN stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-07
lockedlocked$00.00+00.00%2026-06-17Find Out Why
lockedlocked$00.00+00.00%2026-06-17Find Out Why
lockedlocked$00.00+00.00%2026-03-30Find Out Why

1 of 1

Forecast return on equity

Is GRDN forecast to generate an efficient return?

Company
41.74%
Industry
-55.93%
Market
149.97%
GRDN's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GRDN forecast to generate an efficient return on assets?

Company
23.11%
Industry
9.74%
GRDN is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GRDN earnings per share forecast

What is GRDN's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$1.27+21.19%
Avg 2 year Forecast
$1.54+46.2%
Avg 3 year Forecast
$1.62+54.13%
GRDN's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

GRDN revenue forecast

What is GRDN's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$1.5B+0.11%
Avg 2 year Forecast
$1.6B+6.6%
Avg 3 year Forecast
$1.7B+16.92%
GRDN's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GRDN earnings growth forecast

How is GRDN forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
18.75%
Industry
7.33%
Market
63.77%
GRDN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
GRDN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
GRDN's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

GRDN revenue growth forecast

How is GRDN forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
3.81%
Industry
4.15%
Market
14.89%
GRDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GRDN's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GRDN vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
GRDN$46.49$46.75+0.56%Strong Buy
BKD$11.91$19.00+59.53%Strong Buy
AVAH$14.38$14.25-0.90%Buy
ACHC$28.00$34.63+23.66%Strong Buy
NHC$227.76N/AN/A
View Top Medical Care Facility Stocks

Guardian Pharmacy Services Stock Forecast FAQ

Is Guardian Pharmacy Services Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 4 Wall Street analysts covering (NYSE: GRDN) stock is to Strong Buy GRDN stock.

Out of 4 analysts, 3 (75%) are recommending GRDN as a Strong Buy, 1 (25%) are recommending GRDN as a Buy, 0 (0%) are recommending GRDN as a Hold, 0 (0%) are recommending GRDN as a Sell, and 0 (0%) are recommending GRDN as a Strong Sell.

If you're new to stock investing, here's how to buy Guardian Pharmacy Services stock.

What is GRDN's earnings growth forecast for 2026-2028?

(NYSE: GRDN) Guardian Pharmacy Services's forecast annual earnings growth rate of 18.75% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 7.33%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 63.77%.

Guardian Pharmacy Services's earnings in 2026 is $65,908,000.On average, 8 Wall Street analysts forecast GRDN's earnings for 2026 to be $80,603,082, with the lowest GRDN earnings forecast at $70,766,022, and the highest GRDN earnings forecast at $91,117,904. On average, 8 Wall Street analysts forecast GRDN's earnings for 2027 to be $97,236,771, with the lowest GRDN earnings forecast at $88,767,905, and the highest GRDN earnings forecast at $109,740,542.

In 2028, GRDN is forecast to generate $102,513,185 in earnings, with the lowest earnings forecast at $81,939,604 and the highest earnings forecast at $118,386,766.

What is GRDN's revenue growth forecast for 2026-2028?

(NYSE: GRDN) Guardian Pharmacy Services's forecast annual revenue growth rate of 3.81% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.15%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.89%.

Guardian Pharmacy Services's revenue in 2026 is $1,463,406,000.On average, 8 Wall Street analysts forecast GRDN's revenue for 2026 to be $92,796,475,360, with the lowest GRDN revenue forecast at $87,855,775,648, and the highest GRDN revenue forecast at $95,900,248,256. On average, 8 Wall Street analysts forecast GRDN's revenue for 2027 to be $98,813,994,240, with the lowest GRDN revenue forecast at $92,923,159,968, and the highest GRDN revenue forecast at $103,754,693,952.

In 2028, GRDN is forecast to generate $108,378,682,144 in revenue, with the lowest revenue forecast at $101,664,397,920 and the highest revenue forecast at $113,762,777,984.

What is GRDN's forecast return on assets (ROA) for 2026-2028?

(NYSE: GRDN) forecast ROA is 23.11%, which is higher than the forecast US Medical Care Facilities industry average of 9.74%.

What is GRDN's Price Target?

According to 4 Wall Street analysts that have issued a 1 year GRDN price target, the average GRDN price target is $46.75, with the highest GRDN stock price forecast at $49.00 and the lowest GRDN stock price forecast at $44.00.

On average, Wall Street analysts predict that Guardian Pharmacy Services's share price could reach $46.75 by Aug 7, 2027. The average Guardian Pharmacy Services stock price prediction forecasts a potential upside of 0.56% from the current GRDN share price of $46.49.

What is GRDN's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: GRDN) Guardian Pharmacy Services's current Earnings Per Share (EPS) is $1.05. On average, analysts forecast that GRDN's EPS will be $1.27 for 2026, with the lowest EPS forecast at $1.12, and the highest EPS forecast at $1.44. On average, analysts forecast that GRDN's EPS will be $1.54 for 2027, with the lowest EPS forecast at $1.40, and the highest EPS forecast at $1.73. In 2028, GRDN's EPS is forecast to hit $1.62 (min: $1.29, max: $1.87).

What is GRDN's forecast return on equity (ROE) for 2026-2028?

(NYSE: GRDN) forecast ROE is 41.74%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.